NOVAVAX INC Business Finance Contracts & Agreements

99 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Subscription Agreement, dated May 10, 2024, by and between Novavax, Inc. and Sanofi Pasteur Inc
Subscription Agreements
NOVAVAX INC
Biotechnology
NY
2024
Modification No. 21 to Undefinitized Project Agreement No. 1, dated February 6, 2024, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Modification No. 20 to Undefinitized Project Agreement No. 1, dated December 1, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Modification No. 19 to Undefinitized Project Agreement No. 1, dated September 19, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Securities Subscription Agreement, dated as of August 8, 2023, between Novavax, Inc. and SK bioscience Co., Ltd
Subscription Agreements
NOVAVAX INC
Biotechnology
NY
2023
Form of Non-Statutory Stock Option Award Agreement
Stock Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 4 to Advanced Purchase Agreement, dated as of July 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 3 to Advanced Purchase Agreement, dated as of April 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 2 to Advanced Purchase Agreement, dated as of April 6, 2022, between the Company and the Commonwealth of Australia as Represented by the Department of Health
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 4 to Advanced Purchase Agreement, effective as of June 30, 2023, between the Company and His Majesty the King in Right of Canada, as represented by the Minister of...
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 3 to Advanced Purchase Agreement, effective as of
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 2 to Advanced Purchase Agreement, effective as of
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Amendment No. 1 to Advanced Purchase Agreement, effective as of
Purchase Agreements
NOVAVAX INC
Biotechnology
2023
Modification No. 18 to Undefinitized Project Agreement No. 1, dated May 25, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Modification No. 17 to Undefinitized Project Agreement No. 1, dated February 6, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Modification No. 03 to Base Agreement between the Company and Advanced Technology International, dated as of November 30, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Form of Restricted Stock Unit Award Agreement under the Novavax, Inc. 2023 Inducement Plan
Stock Agreements
NOVAVAX INC
Biotechnology
2023
Form of Non-Statutory Stock Option Agreement under the Novavax, Inc. 2023 Inducement Plan
Stock Agreements
NOVAVAX INC
Biotechnology
2023
Indenture, dated as of December 20, 2022, between Novavax, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
NOVAVAX INC
Biotechnology
NY
2022
Underwriting Agreement, dated as of December 15, 2022, between Novavax, Inc. and J.P. Morgan Securities LLC, Jefferies LLC and Cowen and Company, LLC, as representatives of the...
Underwriting Agreements
NOVAVAX INC
Biotechnology
CA
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 02 to Base Agreement between the Company and Advanced Technology International, dated as of August 2, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 01 to Base Agreement between Novavax, Inc. and Advanced Technology International, dated as of March 23, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 13 to Undefinitized Project Agreement No. 01, dated February 1, 2022, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 12 to Undefinitized Project Agreement No. 01, dated December 20, 2021, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Amendment to Advance Purchase Agreement between the Company, and the Commonwealth of Australia as represented by the Department of Health, dated as of December 23, 2021
Purchase Agreements
NOVAVAX INC
Biotechnology
2022
Advance Purchase Agreement, dated August 16, 2021, between Novavax, Inc., Novavax CZ and the European Commission
Purchase Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 11 to Undefinitized Project Agreement No. 1, dated August 26, 2021, between Novavax, Inc. and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 10 to Undefinitized Project Agreement No. 1, dated August 6, 2021, between Novavax, Inc. and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 09 to Undefinitized Project Agreement No. 1, dated July 16, 2021, between Novavax, Inc. and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 08 to Undefinitized Project Agreement No. 1, dated June 4, 2021, between Novavax, Inc. and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 07 to Undefinitized Project Agreement No. 1, dated April 23, 2021, between Novavax, Inc. and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Advance Purchase Agreement, dated May 5, 2021, between Novavax, Inc. and the Gavi Alliance
Purchase Agreements
NOVAVAX INC
Biotechnology
2021
Amendment Number 1 to the iPDP and Budget of the Outbreak Response Funding Agreement (Step 2), entered into on November 2, 2020, between Novavax, Inc. and the Coalition for...
Funding Agreements
NOVAVAX INC
Biotechnology
2021
Amendment of Solicitation/Modification of Contract, Modification No. 3, entered into January 5, 2021, between the Company and the U.S. Department of Defense Joint Program...
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Amendment of Solicitation/Modification of Contract, Modification No. 2, entered into December 1, 2020, between the Company and the U.S. Department of Defense Joint Program...
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 06 to Undefinitized Project Agreement No. 01, entered into January 19, 2021, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021
Modification No. 05 to Undefinitized Project Agreement No. 01, dated January 12, 2021, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2021